Fiche publication
Date publication
octobre 2017
Journal
Disease models & mechanisms
Auteurs
Membres identifiés du Cancéropôle Est :
Dr HERAULT Yann
Tous les auteurs :
Herault Y, Delabar JM, Fisher EMC, Tybulewicz VLJ, Yu E, Brault V
Lien Pubmed
Résumé
Down syndrome is caused by trisomy of chromosome 21. To date, a multiplicity of mouse models with Down-syndrome-related features has been developed to understand this complex human chromosomal disorder. These mouse models have been important for determining genotype-phenotype relationships and identification of dosage-sensitive genes involved in the pathophysiology of the condition, and in exploring the impact of the additional chromosome on the whole genome. Mouse models of Down syndrome have also been used to test therapeutic strategies. Here, we provide an overview of research in the last 15 years dedicated to the development and application of rodent models for Down syndrome. We also speculate on possible and probable future directions of research in this fast-moving field. As our understanding of the syndrome improves and genome engineering technologies evolve, it is necessary to coordinate efforts to make all Down syndrome models available to the community, to test therapeutics in models that replicate the whole trisomy and design new animal models to promote further discovery of potential therapeutic targets.
Mots clés
Aneuploidy, Chromosome engineering, Dosage-senstive gene, Down syndrome, Mouse model
Référence
Dis Model Mech. 2017 Oct;10(10):1165-1186
